Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer
暂无分享,去创建一个
S. Kudoh | Y. Ichinose | M. Fukuoka | Y. Ohashi | M. Takada | K. Furuse | T. Sugiura | F. T. O. C. Group | M. Kawahara | K. Hasegawa | H. Niitani